DGX
Quest Diagnostics Incorporated
Stock
$233.33+2.24 (+0.97%)Close Oct 2, 2026
- Capital expenditures, 2025
- $527M
- YoY, 2025
- +24.0%
- 5-year CAGR
- +4.7%
- 10-year CAGR
- +7.2%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $527M | +24.0% |
| 2024 | $425M | +4.2% |
| 2023 | $408M | +1.0% |
| 2022 | $404M | +0.2% |
| 2021 | $403M | −3.6% |
| 2020 | $418M | +4.5% |
| 2019 | $400M | +4.4% |
| 2018 | $383M | +52.0% |
| 2017 | $252M | −14.0% |
| 2016 | $293M | +11.4% |
| 2015 | $263M | −14.6% |
| 2014 | $308M | +33.3% |
| 2013 | $231M | +26.9% |
| 2012 | $182M | +13.0% |
| 2011 | $161M | −21.6% |
| 2010 | $205M | +23.0% |
| 2009 | $167M | −21.5% |
| 2008 | $213M | −2.9% |
| 2007 | $219M | — |